HARROW, INC. — Director's Dealing 2013

May 7, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2013-05-02

Reporting Person: BAUM MARK L (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-02	Common Stock	A	1050000	—	Acquired	1219835	Direct
2013-05-02	Common Stock	A	200000	—	Acquired	1419835	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-02	Option - Right to Buy	$8.99	A	180000	Acquired	2023-05-02	Common Stock (180000)	Direct

Footnotes

F1: Represents performance-based restricted stock units (the "PSUs") granted under the Issuer's 2007 Stock Incentive and Awards Plan (the "Plan"). The PSUs settle in common stock of the Issuer on the third anniversary of the grant date upon the satisfaction of certain stock-price based performance targets during the term of the PSUs.

F2: Represents restricted stock units ("RSUs") issued under the Plan. The RSUs settle in common stock of the Issuer on the third anniversary of the grant.

F3: Represents stock options granted under the Plan. The stock options vest on a quarterly basis over a three year period.